Dr. Wang Wenping (王文平) - Chief Physician & Professor of Ultrasound Medicine in Shanghai

About Dr. Wang Wenping (王文平)

Dr. Wang Wenping is a Professor and Chief Physician in the Department of Ultrasound Medicine at Zhongshan Hospital, Fudan University — one of China's most prestigious academic medical centers. Widely regarded as one of China's foremost authorities in diagnostic and interventional ultrasound, Dr. Wang has dedicated her career to advancing the role of ultrasound in the detection, characterization, and minimally invasive treatment of liver tumors, abdominal masses, and other complex conditions.

Dr. Wang leads one of China's highest-volume ultrasound departments and is a national leader in contrast-enhanced ultrasound (CEUS), ultrasound-guided tumor ablation (radiofrequency ablation and microwave ablation), and ultrasound-guided biopsy. Her work has been instrumental in establishing CEUS as a standard diagnostic tool for liver lesion characterization in China, and she has trained generations of ultrasound physicians across the country. For international patients, Dr. Wang offers access to world-class non-invasive and minimally invasive diagnostic and therapeutic options that can frequently replace more invasive surgical or radiological procedures.

Core Clinical Specializations

1. Hepatic Ultrasound & Liver Lesion Characterization

Conditions Evaluated:

• Hepatocellular carcinoma (HCC) — detection, characterization, and treatment monitoring
• Liver metastases — detection and response assessment
• Intrahepatic cholangiocarcinoma
• Benign liver lesions: hemangioma, focal nodular hyperplasia (FNH), hepatic adenoma, simple cysts
• Liver cirrhosis and portal hypertension assessment
• Fatty liver disease (NAFLD/NASH) — grading and fibrosis assessment

Diagnostic Techniques:

• High-resolution B-mode and Doppler ultrasound
• Contrast-enhanced ultrasound (CEUS) with SonoVue — real-time dynamic liver lesion characterization without radiation or nephrotoxic contrast
• Ultrasound elastography (shear wave elastography) for liver fibrosis staging
• 3D ultrasound for lesion volume assessment and treatment planning
• Fusion imaging (ultrasound/CT or ultrasound/MRI co-registration) for lesion targeting

Clinical Advantages of CEUS:

• Real-time dynamic imaging of lesion vascularity — superior to CT/MRI for characterizing small liver lesions
• No ionizing radiation — safe for repeated use and in patients with contrast allergy or renal impairment
• Immediate bedside availability — results available during the same appointment
• Cost-effective alternative or complement to CT and MRI for liver surveillance

2. Interventional Ultrasound — Tumor Ablation

Procedures Performed:

• Ultrasound-guided radiofrequency ablation (RFA) for liver tumors (HCC and metastases)
• Ultrasound-guided microwave ablation (MWA) for liver, kidney, thyroid, and adrenal tumors
• Ultrasound-guided cryoablation for select tumors
• Combination ablation + TACE (transarterial chemoembolization) for intermediate HCC
• Ablation of recurrent HCC post-resection or post-transplant

Indications & Patient Selection:

• Early HCC (single lesion ≤5cm, or up to 3 lesions ≤3cm) — curative intent ablation
• Liver metastases not amenable to surgical resection
• Patients with impaired liver function (Child-Pugh B) not suitable for surgery
• Recurrent HCC after prior resection or ablation
• Patients preferring minimally invasive treatment over surgery

Clinical Outcomes:

• Local tumor control rates for early HCC comparable to surgical resection in selected patients
• Procedure performed under ultrasound guidance with real-time monitoring — no radiation exposure
• Typically performed under general anesthesia or deep sedation; hospital stay 1–3 days
• Immediate post-ablation CEUS to confirm complete ablation

3. Ultrasound-Guided Biopsy & Drainage

Procedures Performed:

• Ultrasound-guided percutaneous liver biopsy (core needle biopsy for diffuse liver disease and focal lesions)
• Fine needle aspiration (FNA) and core biopsy of abdominal masses, lymph nodes, and soft tissue tumors
• Thyroid nodule FNA and core biopsy
• Ultrasound-guided drainage of abdominal abscesses, ascites, pleural effusions, and bilomas
• Ultrasound-guided nephrostomy and renal cyst aspiration

4. Abdominal & Pelvic Ultrasound

Organs & Conditions Evaluated:

• Gallbladder and biliary tract (cholelithiasis, cholecystitis, biliary strictures, cholangiocarcinoma)
• Pancreas (pancreatitis, pancreatic cysts, pancreatic tumors)
• Kidneys and adrenal glands (renal cell carcinoma, adrenal masses, hydronephrosis)
• Spleen (splenomegaly, splenic lesions)
• Thyroid and parathyroid glands
• Abdominal lymphadenopathy
• Pelvic organs (uterus, ovaries) — gynecological ultrasound

Academic Achievements & National Leadership

• Professor of Medicine, Fudan University
• Chief Physician, Department of Ultrasound Medicine, Zhongshan Hospital
• Chair or Vice-Chair, Chinese Society of Ultrasound Medicine — Abdominal Ultrasound Group
• Principal contributor to Chinese national guidelines for CEUS and ultrasound-guided interventional procedures
• Author of over 150 peer-reviewed publications in Chinese and international radiology and ultrasound journals
• Editor of major Chinese ultrasound medicine textbooks
• Invited faculty at major international ultrasound and radiology conferences (EUROSON, WFUMB, ECR, RSNA)
• Trainer of ultrasound physicians from across China and internationally

Why International Patients Choose Dr. Wang Wenping

• Non-invasive liver lesion diagnosis: CEUS under Dr. Wang's expertise can definitively characterize liver lesions that are indeterminate on CT or MRI, frequently avoiding the need for biopsy or additional imaging.
• Minimally invasive tumor ablation: For eligible liver tumors, ultrasound-guided ablation offers curative or disease-controlling treatment with a 1–3 day hospital stay, no surgical incision, and rapid recovery — ideal for international patients.
• Radiation-free imaging: CEUS uses no ionizing radiation, making it safe for repeated use in cancer surveillance and particularly valuable for younger patients or those requiring frequent monitoring.
• One-stop diagnosis and treatment: In many cases, diagnostic CEUS and therapeutic ablation can be planned and performed within the same admission at Zhongshan Hospital.
• Cost-effectiveness: World-class interventional ultrasound and CEUS at a fraction of the cost compared to equivalent centers in the US, UK, or Europe.

Treatment Protocols & Patient Journey

Step 1: Pre-Consultation Review

CMCS Shanghai coordinates a review of all available imaging (CT, MRI, PET-CT, prior ultrasound reports), laboratory results (AFP, liver function, viral hepatitis serology), and pathology reports before your first appointment with Dr. Wang.

Step 2: In-Person Consultation & Diagnostic Ultrasound

Your consultation includes a detailed clinical assessment and, where indicated, same-day diagnostic ultrasound with CEUS for real-time liver lesion characterization. CMCS provides full medical interpretation throughout.

Step 3: Multidisciplinary Review (Where Indicated)

Liver tumors being considered for ablation are reviewed at Zhongshan Hospital's hepatobiliary MDT meeting, attended by hepatic surgeons, interventional radiologists, oncologists, and hepatologists, to confirm that ablation is the optimal treatment approach.

Step 4: Ablation Procedure

Ultrasound-guided RFA or MWA is performed under general anesthesia or deep sedation. The procedure typically takes 30–90 minutes. Immediate post-ablation CEUS confirms complete tumor ablation before the patient leaves the operating room. Hospital stay is typically 1–3 days.

Step 5: Post-Ablation Assessment & Follow-Up

Follow-up CEUS or contrast-enhanced CT/MRI is performed at 1 month to confirm complete ablation. Subsequent surveillance imaging is scheduled at 3–6 month intervals. CMCS coordinates remote follow-up consultations and can arrange surveillance imaging at Zhongshan Hospital for patients returning to Shanghai.

Frequently Asked Questions

What is contrast-enhanced ultrasound (CEUS) and how is it different from regular ultrasound?

CEUS uses an intravenous microbubble contrast agent (SonoVue) to visualize the blood supply of lesions in real time. Unlike CT or MRI contrast agents, SonoVue is not nephrotoxic and does not involve ionizing radiation. CEUS provides dynamic, real-time imaging of lesion vascularity that is highly accurate for characterizing liver lesions, often matching or exceeding the diagnostic accuracy of contrast-enhanced CT or MRI for small lesions.

Is ultrasound-guided ablation as effective as surgery for early liver cancer?

For early HCC (single lesion ≤3cm), multiple studies have shown that RFA and MWA achieve local tumor control rates comparable to surgical resection, with significantly lower morbidity and shorter recovery time. For lesions between 3–5cm, ablation remains an effective option, particularly for patients with impaired liver function or those who prefer to avoid surgery. Dr. Wang's team selects patients carefully to ensure ablation is performed only when curative intent is achievable.

Can Dr. Wang evaluate a liver lesion found on CT or MRI that is indeterminate?

Yes. CEUS is particularly valuable for characterizing liver lesions that are indeterminate on CT or MRI. In many cases, a single CEUS examination with Dr. Wang can provide a definitive diagnosis, avoiding the need for biopsy or repeat cross-sectional imaging.

What languages does Dr. Wang's team communicate in?

Dr. Wang's clinical team communicates primarily in Mandarin Chinese. CMCS Shanghai provides full English medical interpretation for all consultations and procedures.

How do I send my imaging for pre-consultation review?

Contact CMCS Shanghai via email at contract@medicalsh.com or WeChat (gezhanglao). We will provide secure upload instructions and coordinate the review with Dr. Wang's team within 3–5 business days.

Schedule Your Consultation

If you have a liver lesion, abdominal tumor, or other condition requiring expert ultrasound evaluation or minimally invasive image-guided treatment in Shanghai, CMCS Shanghai can arrange a consultation with Dr. Wang Wenping at Zhongshan Hospital.

• 📧 Email: contract@medicalsh.com
• 💬 WeChat: gezhanglao
• 🌐 Website: medicalsh.com

CMCS Shanghai — Connecting international patients with China's top specialists, from first inquiry to full recovery.

Disclaimer: This profile is intended for educational and informational purposes only. CMCS Shanghai is a medical concierge service and does not provide direct medical care. All clinical decisions are made by licensed physicians at accredited hospitals.